Suppr超能文献

雷米普利拉对离体兔心脏的心脏保护作用。

Cardioprotection by ramiprilat in isolated rabbit hearts.

作者信息

Rump A F, Koreuber D, Rösen R, Klaus W

机构信息

Institut für Pharmakologie, Universität Köln, Germany.

出版信息

Eur J Pharmacol. 1993 Sep 14;241(2-3):201-7. doi: 10.1016/0014-2999(93)90204-u.

Abstract

The anti-ischemic properties of the ACE inhibitor ramiprilat (ram) were investigated in electrically driven Langendorff hearts from rabbits whose endogenous angiotensin-I content has been previously shown to be very low (constant pressure: 70 cm H2O, Tyrode solution, Ca2+ 1.8 mmol/l). Cumulative concentration-response curves showed that the reduction in global coronary flow (CF) by exogenous angiotensin-I was concentration dependently inhibited by ram (P < 0.05). Myocardial ischemia (MI) was induced by occlusion of a left coronary artery branch and MI was quantified by NADH surface fluorescence photography. MI was significantly enlarged (+23%) (P < 0.05) by exogenous angiotensin-I (6 x 10(-9) mol/l). Addition of ram (10(-8) mol/l) to the perfusion buffer simultaneously with angiotensin-I, completely prevented the reduction of CF by angiotensin-I (P > 0.05) and significantly diminished MI even below control values (-25%) (P < 0.05). In the absence of exogenous angiotensin-I, ram alone (10(-8) mol/l) did not significantly enhance CF (P > 0.05), supporting findings demonstrating a very low endogenous angiotensin-I content in isolated rabbit hearts. However, ram alone (10(-8) mol/l) significantly diminished MI (-24%) (P < 0.05). We conclude that ram does possess direct cardioprotective properties that are independent of the inhibition of angiotensin-II generation but that may be related to potentiation of the effects of bradykinin.

摘要

在先前已证明内源性血管紧张素 - I含量非常低的兔离体Langendorff心脏(恒压:70 cm H₂O,台氏液,Ca²⁺ 1.8 mmol/L)中,研究了血管紧张素转换酶抑制剂雷米普利拉(ram)的抗缺血特性。累积浓度 - 反应曲线表明,雷米普利拉浓度依赖性地抑制外源性血管紧张素 - I引起的整体冠状动脉血流量(CF)降低(P < 0.05)。通过结扎左冠状动脉分支诱导心肌缺血(MI),并通过NADH表面荧光摄影对MI进行定量。外源性血管紧张素 - I(6×10⁻⁹ mol/L)可使MI显著扩大(+23%)(P < 0.05)。在灌注缓冲液中与血管紧张素 - I同时加入雷米普利拉(10⁻⁸ mol/L),可完全阻止血管紧张素 - I引起的CF降低(P > 0.05),并使MI显著减小,甚至低于对照值(-25%)(P < 0.05)。在无外源性血管紧张素 - I的情况下,单独使用雷米普利拉(10⁻⁸ mol/L)不会显著增加CF(P > 0.05),这支持了在离体兔心脏中内源性血管紧张素 - I含量非常低的研究结果。然而,单独使用雷米普利拉(10⁻⁸ mol/L)可显著减小MI(-24%)(P < 0.05)。我们得出结论,雷米普利拉确实具有直接的心脏保护特性,这些特性独立于对血管紧张素 - II生成的抑制作用,但可能与增强缓激肽的作用有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验